Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals, Inc. | -1.20% | 723.10 | 2.6% | $745.67m | |
| AMGN | Amgen, Inc. | -0.70% | 229.33 | 1.4% | $604.26m | |
| BIIB | Biogen, Inc. | -1.48% | 258.39 | 1.8% | $571.48m | |
| MRNA | Moderna, Inc. | -4.68% | 119.29 | 0.0% | $562.31m | |
| GILD | Gilead Sciences, Inc. | -1.10% | 64.24 | 1.0% | $544.04m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.51% | 294.12 | 1.9% | $423.43m | |
| ILMN | Illumina, Inc. | -2.92% | 206.50 | 3.2% | $398.83m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 1.99% | 4.10 | 0.7% | $286.61m | |
| SAVA | Cassava Sciences, Inc. | -6.61% | 39.55 | 0.0% | $177.14m | |
| BNTX | BioNTech SE | -1.85% | 134.98 | 0.0% | $107.37m | |
| TECH | Bio-Techne Corp. | -4.80% | 294.25 | 4.5% | $95.93m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -3.95% | 87.87 | 4.2% | $92.14m | |
| PRTA | Prothena Corp. Plc | -3.97% | 56.25 | 13.8% | $76.08m | |
| CRSP | CRISPR Therapeutics AG | -5.23% | 61.85 | 0.6% | $74.13m | |
| NVAX | Novavax, Inc. | -9.62% | 16.34 | 75.6% | $71.84m |
Company Profile
CytRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded in 1985 and is headquartered in Los Angeles, CA.